HemoSense Signs Agreement with Reliant to Distribute INRatio for Home INR Testing.
Reliant will exclusively offer INRatio to its customers, and intends to provide personalized reimbursement assistance to patients, including insurance claims filing and documentation processing. New INRatio customers will also be eligible for face-to-face training from Reliant's nationwide network of healthcare professionals.
"INRatio allows patients to self-test their PT/INR easily and frequently at home. We hope many warfarin patients take advantage of Reliant's personalized services and training to help them get started with INRatio, and we are glad to add Reliant to our patient self-testing distribution network," said Timothy Still, executive vice president of sales and marketing for HemoSense.
Shari Kipp, Reliant's director of sales and marketing, added, "INRatio's simple test procedure makes it a perfect match for our network of face-to-face trainers, and we are excited to partner with HemoSense to offer patients the time savings and health benefits of home INR testing with INRatio."
HemoSense develops, manufactures and markets easy-to-use, handheld blood coagulation systems for monitoring patients taking warfarin. The HemoSense INRatio system, used by healthcare professionals and patients themselves, consists of a small monitor and disposable test strips. It provides accurate and convenient measurement of blood clotting time, or PT/INR values. Routine measurements of PT/INR are necessary for the safe and effective management of the patient's warfarin dosing. INRatio is sold in the United States and internationally. For more information, visit www.hemosense.com.
Reliant Healthcare Solutions is a U.S. provider of home PT/INR testing supplies and related services for eligible Medicare and privately insured individuals, and offers INRatio exclusively to its customers. For more information, call 1-877-INR-AIDE (1-877-467-2433) toll free or send a request to Reliant Healthcare Solutions, 123 E. San Carlos Street #401, San Jose, Calif. 95112.
HemoSense(R) and INRatio(R) are registered trademarks of HemoSense, Inc.
|Printer friendly Cite/link Email Feedback|
|Date:||Feb 28, 2006|
|Previous Article:||Eaton Vance Insured Municipal Bond Funds Declare Monthly Distributions.|
|Next Article:||Cadence Elects CA's John Swainson to Its Board of Directors.|